THE EPIDEMIOLOGICAL AND IMMUNOLOGICAL EFFICIENCY OF USE OF WIFERON GEL IN THE PREVENTION OF INFLUENZA AND OTHER ACUTE RESPIRATORY INFECTIONS IN ORGANIZED MILITARY COLLECTIVE BODIES


Дәйексөз келтіру

Толық мәтін

Аннотация

Influenza and other acute respiratory infections (API) are 35-50% in the structure of overall morbidity among armed forces personnel. The problem of API is particular urgent for military collective bodies at high risk for respiratory tract infections. The application ofwiferon gel for their prevention allows a substantial reduction in the incidence of ARTin the organized military collective bodies (epidemiological efficacy coefficient, 50,2%; efficacy index, 2,0). The military men using this agent also showed 2.1- and 2. 4-fold reductions in the incidence of bronchitis and community- acquired pneumonias, respectively. Wiferon gel was found to have an immunomodulatory effect on the interferon (IFN) system, as confirmed by a statistically significant rise in the peripheral blood cell-induced production of IFN-a in vitro, and on cellular and humoral immunity, by contributing to the increase of total nonspecific resistance to API. The agent is well tolerated, without causing adverse or allergic reactions, and may be recommended for wide use to prevent ARI and their complications in the organized military collective bodies. It is the most expedient to apply the agent for preventive purposes when military units are formed.

Толық мәтін

Рұқсат жабық

Авторлар туралы

V. AKIMKIN

Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare, Moscow; I.M. Sechenov First Moscow State Medical University

Email: vgakimkin@yandex.ru

S. KOROTCHENKO

L.A. Tarasevich State Research Institute for Standardization and Control of Medical Biological Preparations

V. SHEVTSOV

L.A. Tarasevich State Research Institute for Standardization and Control of Medical Biological Preparations

A. VOLGIN

L.A. Tarasevich State Research Institute for Standardization and Control of Medical Biological Preparations

Т. SALMINA

L. KALABUKHOVA

V. MALINOVSKAYA

N.F. Gamaleya Research Institute for Fpidemiology and Microbiology, Russian Academy of Medical Sciences, Moscow

R. GATICH

OOO «FFRON», Moscow

ТА. SEMENENKO

T. GUSEVA

N.F. Gamaleya Research Institute for Fpidemiology and Microbiology, Russian Academy of Medical Sciences, Moscow

O. V PARSHINA

N.F. Gamaleya Research Institute for Fpidemiology and Microbiology, Russian Academy of Medical Sciences, Moscow

E. DMITRIYEVA

OOO «FFRON», Moscow

Әдебиет тізімі

  1. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М.: МедиаСфера. 2002.
  2. Иванов М.В., Акименко М.А. Опыт изучения нейроморфологического субстрата аффективных расстройств в связи с проблемой терапевтической резистентности. Психиатр и психофармакол. 2003; 2:. 56-60.
  3. Полетаев А.Б., Морозов С.Г., Ковалев И.Е. Регуляторная метасистема. М. 2002: 15-17.
  4. Клиническая психоиммунология / Семке В.Я., Ветлугина Т.П., Невидимова Т.П. и др. Томск. 2002: 162-174.
  5. Полетаев А.Б. Иммунофизиология и иммунопатология. М.: МИА. 2008.
  6. Кетлинский С.А., Симбирцев А.С. Цитокины. СПб: Фолиант. 2008 .
  7. Ройт А., Бростофф Дж., Мейл Д. Иммунология.: Пер. с англ. М. 2000.
  8. Хаитов P.M., Игнатьева Г.А., Сидорович И.Г. Иммунология: Учебник. М. 2000.
  9. Карамов Э.В. и др. Мукозный иммунитет и его особенности Иммунология. 2008;6: 377-384.
  10. Москалев А.В., Сбойчаков В.Б. Инфекционная иммунология. СПб. Фолиант. 2006.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2011